Australian Broker Call *Extra* Edition – Feb 11, 2026

Array
(
    [0] => Array
        (
            [0] => ((AEL))
            [1] => ((ALL))
            [2] => ((APE))
            [3] => ((ARB))
            [4] => ((CQE))
            [5] => ((DOW))
            [6] => ((GDF))
            [7] => ((ILA))
            [8] => ((KAR))
            [9] => ((LNW))
            [10] => ((NEU))
            [11] => ((NMG))
            [12] => ((NWS))
            [13] => ((ORG))
            [14] => ((PMT))
            [15] => ((PNI))
            [16] => ((REA))
            [17] => ((STO))
            [18] => ((WDS))
        )

    [1] => Array
        (
            [0] => AEL
            [1] => ALL
            [2] => APE
            [3] => ARB
            [4] => CQE
            [5] => DOW
            [6] => GDF
            [7] => ILA
            [8] => KAR
            [9] => LNW
            [10] => NEU
            [11] => NMG
            [12] => NWS
            [13] => ORG
            [14] => PMT
            [15] => PNI
            [16] => REA
            [17] => STO
            [18] => WDS
        )

)

This story features AMPLITUDE ENERGY LIMITED, and other companies.
For more info SHARE ANALYSIS: AEL
The company is included in ASX300 and ALL-ORDS

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

AEL   ALL   APE   ARB   CQE   DOW   GDF   ILA   KAR   LNW   NEU   NMG   NWS   ORG   PMT   PNI   REA   STO   WDS  

AEL    AMPLITUDE ENERGY LIMITED

Crude Oil – Overnight Price: $2.50

Jarden rates ((AEL)) as Buy (1) –

Amplitude Energy will deliver its first half results on February 25.

With exploration firmly in focus, Jarden looks for updates on the two-well Otway drilling program as well as any further information on recent nearby gas discoveries that could enhance prospectivity and commercialisation paths.

The broker also wants to see progress on debottlenecking and regulatory headroom that can lift capacity further, as well as incremental updates on longer-dated options such as Patricia and Baleen. Buy rating and $3.40 target.

This report was published on February 5, 2026.

Target price is $3.40 Current Price is $2.50 Difference: $0.9
If AEL meets the Jarden target it will return approximately 36% (excluding dividends, fees and charges).
Current consensus price target is $3.45, suggesting upside of 37.8%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 14.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.86.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 8.6, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 29.1.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 22.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.92.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 12.4, implying annual growth of 44.2%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 20.2.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ALL    ARISTOCRAT LEISURE LIMITED

Gaming – Overnight Price: $52.60

Jarden rates ((ALL)) as Buy (1) –

Jarden notes US land-based gaming continues to be resilient and tribal markets remain the primary driver of above-inflation growth. Commercial markets face headwinds from competing channels yet remain positive in terms of demand.

The broker’s tracked commercial data indicates fourth quarter growth of 1.4%, which remains supportive for gaming suppliers. Aristocrat Leisure is expected to be well-placed to take further market share and a Buy rating and $72 target are retained.

This report was published on February 5, 2026.

Target price is $72.00 Current Price is $52.60 Difference: $19.4
If ALL meets the Jarden target it will return approximately 37% (excluding dividends, fees and charges).
Current consensus price target is $72.87, suggesting upside of 38.5%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 105.00 cents and EPS of 274.80 cents.
At the last closing share price the estimated dividend yield is 2.00%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 19.14.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 269.7, implying annual growth of 17.6%.
Current consensus DPS estimate is 96.7, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 19.5.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 115.00 cents and EPS of 311.40 cents.
At the last closing share price the estimated dividend yield is 2.19%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.89.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 301.0, implying annual growth of 11.6%.
Current consensus DPS estimate is 109.0, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 17.5.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

APE    EAGERS AUTOMOTIVE LIMITED

Automobiles & Components – Overnight Price: $25.93

Canaccord Genuity rates ((APE)) as Buy (1) –

Strong new vehicle sales data, up 0.1%, continues in January after 2025 set an all-time record for new vehicle sales, Canaccord Genuity notes, expecting 2026 to be broadly in line with 2025.

Eagers Automotive will shortly close on the purchase of CanadaOne Auto, to be one of the key drivers of the share price performance over the next 12 months.

On that basis, the broker expects Australian vehicle sales numbers will become less relevant although believes an environment where interest rates are rising creates some headwinds.

FY25 results are released in February 19. The broker retains a Buy rating and $33.60 target.

This report was published on February 4, 2026.

Target price is $33.60 Current Price is $25.93 Difference: $7.67
If APE meets the Canaccord Genuity target it will return approximately 30% (excluding dividends, fees and charges).
Current consensus price target is $31.76, suggesting upside of 22.5%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 76.00 cents and EPS of 104.80 cents.
At the last closing share price the estimated dividend yield is 2.93%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.74.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 100.3, implying annual growth of 27.8%.
Current consensus DPS estimate is 74.1, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 25.9.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 95.00 cents and EPS of 140.70 cents.
At the last closing share price the estimated dividend yield is 3.66%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.43.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 123.2, implying annual growth of 22.8%.
Current consensus DPS estimate is 82.9, implying a prospective dividend yield of 3.2%.
Current consensus EPS estimate suggests the PER is 21.0.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ARB    ARB CORPORATION LIMITED

Automobiles & Components – Overnight Price: $24.73

Canaccord Genuity rates ((ARB)) as Hold (3) –

ARB Corp will publish first half results on February 24.

Given the recent market update, Canaccord Genuity expects no significant surprises while commentary around non-US export sales weakness and margin outcomes will be important for the share price performance over the next six months.

Volatility persists in the Top 11 index sales, which declined -13.1% in January and Toyota Prado was a key driver of this weakness. Hold rating. Target is $29.60.

This report was published on February 4, 2026.

Target price is $29.60 Current Price is $24.73 Difference: $4.87
If ARB meets the Canaccord Genuity target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $36.48, suggesting upside of 47.5%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 60.00 cents and EPS of 107.00 cents.
At the last closing share price the estimated dividend yield is 2.43%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.11.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 111.5, implying annual growth of -5.3%.
Current consensus DPS estimate is 63.1, implying a prospective dividend yield of 2.6%.
Current consensus EPS estimate suggests the PER is 22.2.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 78.00 cents and EPS of 122.00 cents.
At the last closing share price the estimated dividend yield is 3.15%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.27.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 129.8, implying annual growth of 16.4%.
Current consensus DPS estimate is 73.6, implying a prospective dividend yield of 3.0%.
Current consensus EPS estimate suggests the PER is 19.1.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CQE    CHARTER HALL SOCIAL INFRASTRUCTURE REIT

Childcare – Overnight Price: $2.90

Canaccord Genuity rates ((CQE)) as Buy (1) –

Charter Hall Social Infrastructure REIT posted underlying net profit of $31.4m, ahead of Canaccord Genuity’s estimates. The results were achieved despite higher-than-expected interest expense.

While debt markets continue to dictate the share price, the broker is impressed by the company’s performance, assessing the current yield spread attractive alongside encouraging earnings growth.

The share price now has around 37% upside to the first half NTA per share. Triple net leases, secure tenant base, and firm rental growth mean the businesss is very predictable in terms of income generation, commentary states.

Buy rating maintained. Target is reduced to $3.16 from $3.41.

This report was published on February 4, 2026.

Target price is $3.16 Current Price is $2.90 Difference: $0.26
If CQE meets the Canaccord Genuity target it will return approximately 9% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 17.00 cents and EPS of 17.40 cents.
At the last closing share price the estimated dividend yield is 5.86%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.67.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 17.80 cents and EPS of 18.10 cents.
At the last closing share price the estimated dividend yield is 6.14%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.02.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

DOW    DOWNER EDI LIMITED

Industrial Sector Contractors & Engineers – Overnight Price: $7.92

Canaccord Genuity rates ((DOW)) as Initiation of coverage with Buy (1) –

Canaccord Genuity initiates coverage of Downer EDI with a positive stance, arguing the company has emerged from a multi-year reset with a simpler structure, improved margins and more predictable earnings.

The broker highlights Downer’s refocus on essential services across transport, energy and facilities, which is reducing exposure to large, higher-risk construction contracts while lifting return quality.

A substantial divestment program since 2023 has sharpened the earnings profile and strengthened cash generation, supporting ongoing debt reduction and dividends.

Canaccord sees scope for steady margin expansion and earnings growth from FY26, underpinned by long-dated contracts and strong work-in-hand visibility. Buy initiated with an $8.58 target.

This report was published on January 29, 2026.

Target price is $8.58 Current Price is $7.92 Difference: $0.66
If DOW meets the Canaccord Genuity target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $8.45, suggesting upside of 6.7%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 28.50 cents and EPS of 41.00 cents.
At the last closing share price the estimated dividend yield is 3.60%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 19.32.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 42.7, implying annual growth of 109.5%.
Current consensus DPS estimate is 27.9, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 18.5.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 33.00 cents and EPS of 45.00 cents.
At the last closing share price the estimated dividend yield is 4.17%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.60.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 47.3, implying annual growth of 10.8%.
Current consensus DPS estimate is 31.0, implying a prospective dividend yield of 3.9%.
Current consensus EPS estimate suggests the PER is 16.7.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

GDF    GARDA PROPERTY GROUP

REITs – Overnight Price: $1.17

Moelis rates ((GDF)) as Buy (1) –

Garda Property has upgraded guidance, expecting lending to make up 46% of revenue in FY26. This has led to a 10% upgrade to FY26 EPS guidance. More growth is expected as vacant industrial space is leased.

Moelis increases its earnings profile in line with guidance, underpinned by a larger lending book and offset by a slower letting period at Acacia Ridge. Buy rating and $1.62 target retained.

This report was published on February 6, 2026.

Target price is $1.62 Current Price is $1.17 Difference: $0.45
If GDF meets the Moelis target it will return approximately 38% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Moelis forecasts a full year FY26 dividend of 8.50 cents and EPS of 10.00 cents.
At the last closing share price the estimated dividend yield is 7.26%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.70.

Forecast for FY27:

Moelis forecasts a full year FY27 dividend of 9.30 cents and EPS of 10.90 cents.
At the last closing share price the estimated dividend yield is 7.95%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.73.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ILA    ISLAND PHARMACEUTICALS LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.42

Research as a Service (RaaS) rates ((ILA)) as No Rating (-1) –

Island Pharmaceuticals has announced feedback from the US FDA on how to progress Galidesivir for approval under the Animal Rule pathway. The FDA provided guidance for regulatory alignment and this is considered a further de-risking event for the business as no more clarifying questions were required.

Pivotal study efficacy results are likely to be available in late 2026. Separately, the company has also raised $9m in a placement at $0.35 a share. It is now fully funded to complete the program and make its new drug submission.

It will become the first Australian biotech to deliver a drug by the Animal Rule pathway. Research as a Service (RaaS) provides a $1.24 valuation, raised from $1.14.

Research as a Service (RaaS) research doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.

This report was published on February 6, 2026.

Target price is $1.24 Current Price is $0.42 Difference: $0.82
If ILA meets the Research as a Service (RaaS) target it will return approximately 195% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.77 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 23.73.

Forecast for FY27:

Research as a Service (RaaS) forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 4.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 8.94.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

KAR    KAROON ENERGY LIMITED

Crude Oil – Overnight Price: $1.69

Jarden rates ((KAR)) as Overweight (2) –

Karoon Energy will deliver its 2025 results on February 26 and Jarden looks for confirmation that the intensive maintenance and optimisation campaign in Brazil will be delivered without further cost or slippage in the schedule.

The broker also wants clarity on the Who Dat East timing and the prospect of US royalty relief. Overweight rating and $1.75 target.

This report was published on February 5, 2026.

Target price is $1.75 Current Price is $1.69 Difference: $0.06
If KAR meets the Jarden target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $1.86, suggesting upside of 10.2%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 4.61 cents and EPS of 17.35 cents.
At the last closing share price the estimated dividend yield is 2.73%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.74.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 18.9, implying annual growth of N/A.
Current consensus DPS estimate is 5.9, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 8.9.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 4.61 cents and EPS of 17.50 cents.
At the last closing share price the estimated dividend yield is 2.73%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.66.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.6, implying annual growth of -28.0%.
Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 2.4%.
Current consensus EPS estimate suggests the PER is 12.4.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

LNW    LIGHT & WONDER INC

Gaming – Overnight Price: $164.07

Jarden rates ((LNW)) as Buy (1) –

Jarden notes US land-based gaming continues to be resilient and tribal markets remain the primary driver of above-inflation growth. Commercial markets face headwinds from competing channels yet remain positive in terms of demand.

The broker’s tracked commercial data indicates fourth quarter growth of 1.4%, which remains supportive for gaming suppliers. Light & Wonder has strong momentum and is expected to achieve its FY28 installed base target of 20% market share.

Buy rating retained. Target is $195.

This report was published on February 5, 2026.

Target price is $195.00 Current Price is $164.07 Difference: $30.93
If LNW meets the Jarden target it will return approximately 19% (excluding dividends, fees and charges).
Current consensus price target is $204.43, suggesting upside of 24.6%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 1022.57 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.04.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 826.9, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 19.8.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 1203.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.63.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 1045.6, implying annual growth of 26.4%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 15.7.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NEU    NEUREN PHARMACEUTICALS LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $13.51

Canaccord Genuity rates ((NEU)) as Buy (1) –

Neuren Pharmaceuticals is now in a trading halt pending an announcement regarding FDA feedback on its Pitt Hopkins Syndrome and hypoxic-ischemic encephalopathy programs.

Canaccord Genuity currently does not include value for this program in its assessment of the stock.

The company has had ongoing constructive conversations with the FDA in relation to its program and the broker would be surprised if additional extensive clinical data are mandated.

No change to Buy rating or $23 target.

This report was published on February 4, 2026.

Target price is $23.00 Current Price is $13.51 Difference: $9.49
If NEU meets the Canaccord Genuity target it will return approximately 70% (excluding dividends, fees and charges).
Current consensus price target is $24.57, suggesting upside of 81.8%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 17.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 79.47.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.7, implying annual growth of -87.7%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 98.6.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 61.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 22.15.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 14.8, implying annual growth of 8.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 91.3.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NMG    NEW MURCHISON GOLD LIMITED

Gold & Silver – Overnight Price: $0.07

Taylor Collison rates ((NMG)) as Speculative Buy (1) –

New Murchison Gold has moved quickly from first production to become a larger-scale producer, Taylor Collison observes.

Commentary highlights December quarter production has confirmed the Crown Prince can generate meaningful cash from high-grade oxide ore, with softer material unlocking additional capacity at the Westgold Bluebird mill and allowing the company to sell more ore than originally agreed.

There is no debt and no hedging and the business is no longer constrained to a single development pathway.

The broker envisages material upside if operating performance exceeds expectations, and the market would then be likely to price the stock as a scalable, multi-asset producer. Target is 7.9 cents. Speculative Buy rating.

This report was published on February 3, 2026.

Target price is $0.08 Current Price is $0.07 Difference: $0.009
If NMG meets the Taylor Collison target it will return approximately 13% (excluding dividends, fees and charges).

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NWS    NEWS CORPORATION

Print, Radio & TV – Overnight Price: $37.36

Jarden rates ((NWS)) as Overweight (2) –

News Corp posted a “solid” result in its second quarter, Jarden observes, with headline EBITDA ahead of expectations. Digital real estate services were broadly in line, while the broker highlights a 10% increase in the revenue for Move.

Strong momentum continued for Dow Jones with professional information services revenue growing 12%.

The company has highlighted an expanded buyback program and partnership with Bloomberg to include AI rights on the Dow Jones content. Overweight. Target is $48.60.

This report was published on February 6, 2026.

Target price is $48.60 Current Price is $37.36 Difference: $11.24
If NWS meets the Jarden target it will return approximately 30% (excluding dividends, fees and charges).
Current consensus price target is $54.95, suggesting upside of 47.1%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 30.71 cents and EPS of 156.30 cents.
At the last closing share price the estimated dividend yield is 0.82%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.90.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 150.5, implying annual growth of N/A.
Current consensus DPS estimate is 28.3, implying a prospective dividend yield of 0.8%.
Current consensus EPS estimate suggests the PER is 24.8.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 30.71 cents and EPS of 179.64 cents.
At the last closing share price the estimated dividend yield is 0.82%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.80.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 186.6, implying annual growth of 24.0%.
Current consensus DPS estimate is 28.3, implying a prospective dividend yield of 0.8%.
Current consensus EPS estimate suggests the PER is 20.0.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ORG    ORIGIN ENERGY LIMITED

Infrastructure & Utilities – Overnight Price: $10.99

Jarden rates ((ORG)) as Neutral (3) –

Ahead of the Origin Energy results on February 12 Jarden asserts 2026 is shaping up as a transition year and looks for clearer signalling on the IPO timing for Kraken and whether the company intends to retain, sell down, exit or distribute its stake.

Also an indication of increased upstream investment of AP LNG to sustain higher output for longer is required. Neutral. Target is $11.65.

This report was published on February 5, 2026.

Target price is $11.65 Current Price is $10.99 Difference: $0.66
If ORG meets the Jarden target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $12.03, suggesting upside of 9.4%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 60.00 cents and EPS of 65.50 cents.
At the last closing share price the estimated dividend yield is 5.46%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.78.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 66.1, implying annual growth of -23.3%.
Current consensus DPS estimate is 60.8, implying a prospective dividend yield of 5.5%.
Current consensus EPS estimate suggests the PER is 16.6.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 60.00 cents and EPS of 58.30 cents.
At the last closing share price the estimated dividend yield is 5.46%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.85.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 58.2, implying annual growth of -12.0%.
Current consensus DPS estimate is 61.8, implying a prospective dividend yield of 5.6%.
Current consensus EPS estimate suggests the PER is 18.9.

Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

PMT    PMET RESOURCES INC

Mining – Overnight Price: $0.58

Canaccord Genuity rates ((PMT)) as Speculative Buy (1) –

Wide high-grade caesium results have been returned from PMET Resources’ 2025 drill campaign across Vega, Rigel and Helios, and Canaccord Genuity has taken note.

Canaccord Genuity notes caesium is one of the least abundant elements on earth and its characteristics make it valuable for unique applications.

Speculative Buy retained. Target is $0.95.

This report was published on February 4, 2026.

Target price is $0.95 Current Price is $0.58 Difference: $0.37
If PMT meets the Canaccord Genuity target it will return approximately 64% (excluding dividends, fees and charges).
Current consensus price target is $0.80, suggesting upside of 38.6%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is -2.8, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY27:

Current consensus EPS estimate is -2.9, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

This company reports in CAD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

PNI    PINNACLE INVESTMENT MANAGEMENT GROUP LIMITED

Wealth Management & Investments – Overnight Price: $18.66

Canaccord Genuity rates ((PNI)) as Buy (1) –

Canaccord Genuity removes Pinnacle Investment Management from “under review”, applying a Buy rating and $27.22 target. The company will acquire Pacific Asset Management which is earnings accretive but also significantly strategic.

Increased scale, growth opportunities and the potential for a domestic managed account entry are all features welcomed by the broker.

Moreover, the valuation remains depressed relative to history and the global scale opportunity meaningfully accelerates with the acquisition, the broker concludes.

This report was published on February 5, 2026.

Target price is $27.22 Current Price is $18.66 Difference: $8.56
If PNI meets the Canaccord Genuity target it will return approximately 46% (excluding dividends, fees and charges).
Current consensus price target is $22.23, suggesting upside of 19.1%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 65.00 cents and EPS of 65.90 cents.
At the last closing share price the estimated dividend yield is 3.48%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 28.32.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 67.8, implying annual growth of 7.3%.
Current consensus DPS estimate is 62.0, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 27.5.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 84.00 cents and EPS of 89.50 cents.
At the last closing share price the estimated dividend yield is 4.50%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.85.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 86.2, implying annual growth of 27.1%.
Current consensus DPS estimate is 77.2, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 21.6.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

REA    REA GROUP LIMITED

Real Estate – Overnight Price: $174.87

Jarden rates ((REA)) as Neutral (3) –

REA Group produced a strong result in the first half although it was slightly below Jarden’s estimates.

EBITDA grew by 6.3% and adjusted net profit by 8.5%. Volume guidance has been lowered to -1-3% decline from “broadly in line with last year”.

Jarden lowers FY26 and FY27 estimates for EPS by -2.3%. The broker acknowledges share price weakness around AI-related disruption, but assesses the business has a “protective moat”.

As risks remain elevated, Jarden increases its WACC assumption to 8.84% from 8.55%. Neutral rating unchanged. Target reduced to $177 from $196.

This report was published on February 6, 2026.

Target price is $177.00 Current Price is $174.87 Difference: $2.13
If REA meets the Jarden target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $228.23, suggesting upside of 30.5%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 278.10 cents and EPS of 480.00 cents.
At the last closing share price the estimated dividend yield is 1.59%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 36.43.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 486.3, implying annual growth of -5.3%.
Current consensus DPS estimate is 283.2, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 36.0.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 323.30 cents and EPS of 555.40 cents.
At the last closing share price the estimated dividend yield is 1.85%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 31.49.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 569.1, implying annual growth of 17.0%.
Current consensus DPS estimate is 330.9, implying a prospective dividend yield of 1.9%.
Current consensus EPS estimate suggests the PER is 30.7.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

STO    SANTOS LIMITED

NatGas – Overnight Price: $6.94

Jarden rates ((STO)) as Underweight (4) –

Ahead of the Santos results on February 18, Jarden notes delivery risk is now front of mind for investors.

The broker will be looking for evidence of a clean and reliable ramp up of Barossa and reaffirmation of Pikka first oil and timing of ramp up.

Guidance will also be required on which unsanctioned projects could realistically progress. Underweight rating and $6 target.

This report was published on February 5, 2026.

Target price is $6.00 Current Price is $6.94 Difference: minus $0.94 (current price is over target).
If STO meets the Jarden target it will return approximately minus 14% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $7.22, suggesting upside of 4.0%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 34.55 cents and EPS of 46.22 cents.
At the last closing share price the estimated dividend yield is 4.98%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.02.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 41.8, implying annual growth of N/A.
Current consensus DPS estimate is 32.2, implying a prospective dividend yield of 4.6%.
Current consensus EPS estimate suggests the PER is 16.6.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 33.93 cents and EPS of 40.23 cents.
At the last closing share price the estimated dividend yield is 4.89%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.25.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 43.3, implying annual growth of 3.6%.
Current consensus DPS estimate is 31.8, implying a prospective dividend yield of 4.6%.
Current consensus EPS estimate suggests the PER is 16.0.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

WDS    WOODSIDE ENERGY GROUP LIMITED

NatGas – Overnight Price: $25.93

Jarden rates ((WDS)) as Overweight (2) –

Ahead of Woodside Energy’s results on February 24, Jarden considers the operating backdrop largely de-risked by recent quarterly updates.

The broker will look for confirmation of strategic continuity and more detail on the timing and structure of additional LA LNG equity sell-down as well as reassurance on the Scarborough execution.

Overweight rating and $25.20 target.

This report was published on February 5, 2026.

Target price is $25.20 Current Price is $25.93 Difference: minus $0.73 (current price is over target).
If WDS meets the Jarden target it will return approximately minus 3% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $25.44, suggesting downside of -1.9%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 162.75 cents and EPS of 203.29 cents.
At the last closing share price the estimated dividend yield is 6.28%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.76.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 179.7, implying annual growth of N/A.
Current consensus DPS estimate is 141.9, implying a prospective dividend yield of 5.5%.
Current consensus EPS estimate suggests the PER is 14.4.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 76.77 cents and EPS of 97.34 cents.
At the last closing share price the estimated dividend yield is 2.96%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 97.8, implying annual growth of -45.6%.
Current consensus DPS estimate is 80.6, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 26.5.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Click to view our Glossary of Financial Terms